Source: FinanzNachrichten

Incyte: Incyte to Showcase New Data from its Oncology Portfolio at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

Incyte (Nasdaq: INCY) today announced that multiple abstracts featuring new data from its oncology portfolio will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeti...

Read full article »
Incyte's Competitors | Incyte's News | Incyte's Financials
Stay up-to-date with the latest news on Incyte
Annual Revenue
$1.0-5.0B
Employees
1.0-5.0K
Herve Hoppenot's photo - President & CEO of Incyte

President & CEO

Herve Hoppenot

CEO Approval Rating

74/100

Read more
Stay up-to-date with the latest news on Incyte